NO151009C - Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive stereoisomere 1,4:3,6-dianhydro-2,5-diazido-2,5-dideoxy-hexitoler - Google Patents

Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive stereoisomere 1,4:3,6-dianhydro-2,5-diazido-2,5-dideoxy-hexitoler

Info

Publication number
NO151009C
NO151009C NO810839A NO810839A NO151009C NO 151009 C NO151009 C NO 151009C NO 810839 A NO810839 A NO 810839A NO 810839 A NO810839 A NO 810839A NO 151009 C NO151009 C NO 151009C
Authority
NO
Norway
Prior art keywords
hexitoles
dianhydro
diazido
dideoxy
preparation
Prior art date
Application number
NO810839A
Other languages
English (en)
Norwegian (no)
Other versions
NO810839L (no
NO151009B (no
Inventor
Janos Kuszmann
Gabor Medgyes
Ferenc Andrasi
Pal Berzsenyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO810839L publication Critical patent/NO810839L/no
Publication of NO151009B publication Critical patent/NO151009B/no
Publication of NO151009C publication Critical patent/NO151009C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO810839A 1980-03-12 1981-03-11 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive stereoisomere 1,4:3,6-dianhydro-2,5-diazido-2,5-dideoxy-hexitoler NO151009C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8080580A HU178152B (en) 1980-03-12 1980-03-12 Process for preparing 1,4,3,6-dianhydro-2,5-diazodo-2,5-dideoxy-hexitols

Publications (3)

Publication Number Publication Date
NO810839L NO810839L (no) 1981-09-14
NO151009B NO151009B (no) 1984-10-15
NO151009C true NO151009C (no) 1985-01-23

Family

ID=10950248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810839A NO151009C (no) 1980-03-12 1981-03-11 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive stereoisomere 1,4:3,6-dianhydro-2,5-diazido-2,5-dideoxy-hexitoler

Country Status (20)

Country Link
US (1) US4332818A (de)
JP (1) JPS56166193A (de)
AT (1) AT373890B (de)
BE (1) BE887834A (de)
CH (1) CH651835A5 (de)
CS (1) CS219948B2 (de)
DD (1) DD156814A5 (de)
DE (1) DE3109532C2 (de)
DK (1) DK152676C (de)
ES (1) ES500992A0 (de)
FI (1) FI72519C (de)
FR (1) FR2478105A1 (de)
GB (1) GB2072664B (de)
HU (1) HU178152B (de)
IT (1) IT1189011B (de)
NO (1) NO151009C (de)
PL (1) PL129828B1 (de)
SE (1) SE449994B (de)
SU (1) SU1176842A3 (de)
YU (1) YU59581A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3229412A1 (de) * 1982-08-06 1984-02-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von dianhydrohexitol-gemischen aus hexitolen, dianhydro-idit enthaltende dianhydro-hexitol-gemischen und ihre verwendung zur herstellung von polymeren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2420519A (en) * 1939-05-31 1947-05-13 Atlas Powder Co Etherified anhydro hexitols
US4169152A (en) * 1977-10-31 1979-09-25 Ici Americas Inc. Isohexide and tetrahydrofuran ethers and their carbamates in method of bringing about relaxation of skeletal musculature

Also Published As

Publication number Publication date
FR2478105B1 (de) 1983-11-18
IT8120277A1 (it) 1982-09-11
PL129828B1 (en) 1984-06-30
DK111481A (da) 1981-09-13
IT1189011B (it) 1988-01-28
ES8201584A1 (es) 1982-01-16
ES500992A0 (es) 1982-01-16
DD156814A5 (de) 1982-09-22
PL230096A1 (de) 1982-08-02
CH651835A5 (de) 1985-10-15
DK152676C (da) 1988-08-22
FI72519B (fi) 1987-02-27
FI810760L (fi) 1981-09-13
JPS56166193A (en) 1981-12-21
AT373890B (de) 1984-02-27
SE449994B (sv) 1987-06-01
US4332818A (en) 1982-06-01
FR2478105A1 (fr) 1981-09-18
SU1176842A3 (ru) 1985-08-30
FI72519C (fi) 1987-06-08
YU59581A (en) 1983-09-30
DE3109532C2 (de) 1986-01-30
GB2072664B (en) 1983-09-21
HU178152B (en) 1982-03-28
NO810839L (no) 1981-09-14
DE3109532A1 (de) 1981-12-24
BE887834A (fr) 1981-09-09
NO151009B (no) 1984-10-15
CS219948B2 (en) 1983-03-25
SE8101515L (sv) 1981-09-13
IT8120277A0 (it) 1981-03-11
DK152676B (da) 1988-04-11
GB2072664A (en) 1981-10-07
ATA113181A (de) 1983-07-15

Similar Documents

Publication Publication Date Title
NO161065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner.
NO156752C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO154426C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO156694C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO833521L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme vinylthioacetamido-oxacefalosporinderivater
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO150041C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive lactamforbindelser
NO800920L (no) Fremgangsmaate til fremstilling av nye 1,8-dihydroksy-10-acyl-9-antroner for behandling av psoriasis
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.